BIM
SGMO

BlackRock Investment Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

BlackRock Investment Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$845K Buy
277,184
+1,795
+0.7% +$6.54K ﹤0.01% 2794
2016
Q3 		$1.27M Sell
275,389
-534
-0.2% -$2.72K ﹤0.01% 2499
2016
Q2 		$1.6M Buy
275,923
+40,923
+17% +$261K ﹤0.01% 2292
2016
Q1 		$1.42M Buy
235,000
+3,579
+2% +$21.5K ﹤0.01% 2233
2015
Q4 		$2.11M Buy
231,421
+363
+0.2% +$2.8K ﹤0.01% 2047
2015
Q3 		$1.3M Sell
231,058
-3,370
-1% -$27.8K ﹤0.01% 2397
2015
Q2 		$2.6M Buy
234,428
+46,299
+25% +$597K ﹤0.01% 2018
2015
Q1 		$2.95M Buy
188,129
+3,176
+2% +$49.1K ﹤0.01% 1761
2014
Q4 		$2.81M Sell
184,953
-2,185
-1% -$26.5K ﹤0.01% 1776
2014
Q3 		$2.02M Buy
187,138
+1,246
+0.7% +$16.3K ﹤0.01% 1996
2014
Q2 		$2.84M Buy
185,892
+1,998
+1% +$28.7K ﹤0.01% 1803
2014
Q1 		$3.33M Buy
183,894
+17,072
+10% +$329K ﹤0.01% 1688
2013
Q4 		$2.32M Sell
166,822
-2,050
-1% -$23.6K ﹤0.01% 1923
2013
Q3 		$1.77M Buy
168,872
+25,037
+17% +$249K ﹤0.01% 2037
2013
Q2 		$1.12M Buy
+143,835
New +$1.25M ﹤0.01% 2273

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FC
FIC Capital New York $262M AUM 34.37% 1-Year Est. Return

BlackRock Investment Management's SGMO Position: Q4 2016 in Review

BlackRock Investment Management increased its SANGAMO THERAPEUTICS INC (SGMO) stake by 0.65% in Q4 2016, buying an estimated $6.54K and bringing the position to 277,184 shares worth $845K. The position accounts for ﹤0.01% of the portfolio, ranked #2794.

BlackRock Investment Management first reported a position in SGMO in Q2 2013 and has held it in 15 quarters since. The position peaked at $3.33M in Q1 2014. 126 funds tracked by Wall St. Rank hold SGMO as of Q4 2016.

  • BlackRock Investment Management held 277,184 shares of SANGAMO THERAPEUTICS INC worth $845K as of Q4 2016.
  • BlackRock Investment Management bought 1,795 SANGAMO THERAPEUTICS INC shares in Q4 2016, an estimated $6.54K.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2794 holding.
  • BlackRock Investment Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's SANGAMO THERAPEUTICS INC position peaked at $3.33M in Q1 2014.
  • 126 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.